Industry News
Biotechnology Industry News

How exploiting a protective gene mutation might shield the brain from Alzheimer’s disease
How exploiting a protective gene mutation might shield the brain from Alzheimer's disease aliu Wed, 09/29/2021 - 06:13
AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect
AstraZeneca moves deeper into rare diseases, spending $150M on late-phase hematology prospect ntaylor Wed, 09/29/2021 - 05:09
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough badams Tue, 09/28/2021 - 08:53
Here we go again: Eisai starts rolling FDA approval submission for Biogen-partnered Alzheimer’s drug
Here we go again: Eisai starts rolling FDA approval submission for Biogen-partnered Alzheimer's drug ntaylor Tue, 09/28/2021 - 06:09
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping
Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping badams Tue, 09/28/2021 - 05:18
After $3.2B deal, Sanofi dumps Translate’s mRNA COVID vaccine but hits the gas on switch to modified molecules
After $3.2B deal, Sanofi dumps Translate's mRNA COVID vaccine but hits the gas on switch to modified molecules ntaylor Tue, 09/28/2021 - 05:18
With a phase 3 fail, Biohaven learned the hard way why AstraZeneca dropped a CNS drug in 2018
With a phase 3 fail, Biohaven learned the hard way why AstraZeneca dropped a CNS drug in 2018 klahucik Mon, 09/27/2021 - 10:14
Novel ‘nanosized’ drug carriers tamp down HIV in the brain and other remote tissues in mice
Novel 'nanosized' drug carriers tamp down HIV in the brain and other remote tissues in mice arlene.weintraub Mon, 09/27/2021 - 09:49
Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab
Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab badams Mon, 09/27/2021 - 06:52
Mystery suitor lines up $11B Acceleron acquisition: report
Mystery suitor lines up $11B Acceleron acquisition: report ntaylor Mon, 09/27/2021 - 05:11
Pfizer stumbles close to finish line in growth hormone race, extending the lead of rival Ascendis
Pfizer stumbles close to finish line in growth hormone race, extending the lead of rival Ascendis ntaylor Mon, 09/27/2021 - 04:30
Vaccine boost: Bavarian Nordic gets government support to join 2nd wave of COVID-19 jabs
Vaccine boost: Bavarian Nordic gets government support to join 2nd wave of COVID-19 jabs ntaylor Fri, 09/24/2021 - 08:02
Kids suffer serious adverse reactions in AGTC gene therapy trial
Kids suffer serious adverse reactions in AGTC gene therapy trial ntaylor Fri, 09/24/2021 - 06:17
AstraZeneca makes RNA play, teaming up with startup to advance twist on red-hot modality
AstraZeneca makes RNA play, teaming up with startup to advance twist on red-hot modality ntaylor Thu, 09/23/2021 - 07:34
Repairing heart damage by transiently turning back the clock
Repairing heart damage by transiently turning back the clock aliu Thu, 09/23/2021 - 07:22
Garuda thinks it has cracked the code to off-the-shelf stem cell transplants—and investors are betting $72M to find out
Garuda thinks it has cracked the code to off-the-shelf stem cell transplants—and investors are betting $72M to find out ntaylor Thu, 09/23/2021 - 06:01
Clover’s COVID-19 shot tames delta in pivotal study, delivering boost to global vaccination campaign
Clover's COVID-19 shot tames delta in pivotal study, delivering boost to global vaccination campaign ntaylor Wed, 09/22/2021 - 08:44
FDA objects to Summit’s midstudy pooling of pivotal trials
FDA objects to Summit's midstudy pooling of pivotal trials ntaylor Wed, 09/22/2021 - 07:33
Another research group joins the llama-inspired COVID-19 antibody bandwagon
Another research group joins the llama-inspired COVID-19 antibody bandwagon klahucik Tue, 09/21/2021 - 12:26
The immune system ‘goes rogue’ after a stroke, but new research has found a way to block the pathway in mice
The immune system 'goes rogue' after a stroke, but new research has found a way to block the pathway in mice elucas Tue, 09/21/2021 - 11:10

